相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lysosomal-targeted anticancer half-sandwich iridium(III) complexes modified with lonidamine amide derivatives
Yongkang Xie et al.
APPLIED ORGANOMETALLIC CHEMISTRY (2020)
Thiourea and Guanidine Compounds and Their Iridium Complexes in Drug-Resistant Cancer Cell Lines: Structure-Activity Relationships and Direct Luminescent Imaging
Samuel J. Thomas et al.
CHEMMEDCHEM (2020)
Rhenium-Based Complexes and in Vivo Testing: A Brief History
Miles S. Capper et al.
CHEMBIOCHEM (2020)
Liposomes encapsulated iridium(III) polypyridyl complexes enhance anticancer activity in vitro and in vivo
Lan Bai et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2020)
Identification of novel potent and non-toxic anticancer, anti-angiogenic and antimetastatic rhenium complexes against colorectal carcinoma
Joachim Delasoie et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Synthesis and characterization of novel naphthalene-derivatized tridentate ligands and their net neutral rhenium tricarbonyl complexes and cytotoxic effects on non-small cell lung cancer cells of interest
Taniya Darshani et al.
POLYHEDRON (2020)
Mitochondria-Targeting Click-Derived Pyridinyltriazolylmethylquinoxaline-Based Y-Shaped Binuclear Luminescent Ruthenium(II) and Iridium(III) Complexes as Cancer Theranostic Agents
Nilmadhab Roy et al.
INORGANIC CHEMISTRY (2020)
Systematically altering the lipophilicity of rhenium(I) tricarbonyl anticancer agents to tune the rate at which they induce cell death
Chilaluck C. Konkankit et al.
DALTON TRANSACTIONS (2020)
Ruthenium and iridium based mononuclear and multinuclear complexes: A Breakthrough of Next-Generation anticancer metallopharmaceuticals
Binoy Kar et al.
INORGANICA CHIMICA ACTA (2020)
Hypoxia efficient and glutathione-resistant cytoselective ruthenium(II)-p-cymene-arylimidazophenanthroline complexes: biomolecular interaction and live cell imaging
Ashaparna Mondal et al.
DALTON TRANSACTIONS (2020)
Construction of an iridium(iii)-complex-loaded MOF nanoplatform mediated with a dual-responsive polycationic polymer for photodynamic therapy and cell imaging
Yongxin Zhang et al.
CHEMICAL COMMUNICATIONS (2020)
Mitochondrial DNA targeting and impairment by a dinuclear Ir-Pt complex that overcomes cisplatin resistance
Cheng Zhang et al.
INORGANIC CHEMISTRY FRONTIERS (2020)
Metal Complexes, an Untapped Source of Antibiotic Potential?
Angelo Frei
ANTIBIOTICS-BASEL (2020)
Unveiling the anti-cancer mechanism for half-sandwich and cyclometalated Ir(iii)-based complexes with functionalized α-lipoic acid
Meng-Meng Wang et al.
RSC ADVANCES (2020)
Fluorescent half-sandwich phosphine-sulfonate iridium(III) and ruthenium (II) complexes as potential lysosome-targeted anticancer agents
Qing Du et al.
DYES AND PIGMENTS (2019)
Half-sandwich iridium(III) complexes with α-picolinic acid frameworks and antitumor applications
Hailong Hao et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2019)
Anticancer Cyclometalated Iridium(III) Complexes with Planar Ligands: Mitochondria! DNA Damage and Metabolism Disturbance
Jian-Jun Cao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
Enzo Alessio et al.
MOLECULES (2019)
In Vivo Anticancer Activity of a Rhenium(I) Tricarbonyl Complex
Chilaluck C. Konkankit et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Mitochondrial Localization of Highly Fluorescent and Photostable BODIPY-Based Ruthenium(II), Rhodium(III), and Iridium(III) Metal Complexes
Gajendra Gupta et al.
INORGANIC CHEMISTRY (2019)
Triphenylamine-appended cyclometallated iridium(III) complexes: Preparation, photophysical properties and application in biology/luminescence imaging
Xicheng Liu et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2019)
Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy
Xing-Dong Song et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Near-IR/Visible-Emitting Thiophenyl-Based Ru(II) Complexes: Efficient Photodynamic Therapy, Cellular Uptake, and DNA Binding
Si-Qi Zhang et al.
INORGANIC CHEMISTRY (2019)
Synthesis, Characterization, and Biological Properties of Steroidal Ruthenium(II) and Iridium(111) Complexes Based on the Androst-16-en-3-ol Framework
Vanessa Koch et al.
INORGANIC CHEMISTRY (2019)
Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433
Susan Monro et al.
CHEMICAL REVIEWS (2019)
Mitochondria-Accumulating Rhenium(I) Tricarbonyl Complexes Induce Cell Death via Irreversible Oxidative Stress and Glutathione Metabolism Disturbance
Fang-Xin Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Luminescent anticancer ruthenium(ii)-p-cymene complexes of extended imidazophenanthroline ligands: synthesis, structure, reactivity, biomolecular interactions and live cell imaging
Bidisha Sarkar et al.
DALTON TRANSACTIONS (2019)
Impairment of the autophagy-related lysosomal degradation pathway by an anticancer rhenium(i) complex
Liang He et al.
DALTON TRANSACTIONS (2019)
Isomeric Ir(iii) complexes for tracking mitochondrial pH fluctuations and inducing mitochondrial dysfunction during photodynamic therapy
Haijie Chen et al.
DALTON TRANSACTIONS (2019)
Identification of a rhodium(III) complex as a Wee1 inhibitor against TP53-mutated triple-negative breast cancer cells
Guan-Jun Yang et al.
CHEMICAL COMMUNICATIONS (2018)
Triphenylamine-Appended Half-Sandwich Iridium(III) Complexes and Their Biological Applications
Xiangdong He et al.
CHEMISTRY-AN ASIAN JOURNAL (2018)
Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex
Qiao-Yan Yi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?
Sreekanth Thota et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
A Family of Rhodium Complexes with Selective Toxicity toward Mismatch Repair-Deficient Cancers
Kelsey M. Boyle et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Synthesis and structure of new binuclear ruthenium(II) arene benzil bis(benzoylhydrazone)complexes: investigation on antiproliferative activity and apoptosis induction
Mohamed Subarkhan Mohamed Kasim et al.
INORGANIC CHEMISTRY FRONTIERS (2018)
Mitochondria-targeted half-sandwich rutheniumII diimine complexes: anticancer and antimetastasis via ROS-mediated signalling
Zhishan Xu et al.
INORGANIC CHEMISTRY FRONTIERS (2018)
Influence of the substituent on the phosphine ligand in novel rhenium(i) aldehydes. Synthesis, computational studies and first insights into the antiproliferative activity
Michelle Munoz-Osses et al.
DALTON TRANSACTIONS (2018)
Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity
Cristina Perez-Arnaiz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Lysosome-Targeted Chemotherapeutics: Half-Sandwich Ruthenium(II) Complexes That Are Selectively Toxic to Cancer Cells
Zhenzhen Tian et al.
INORGANIC CHEMISTRY (2018)
BODIPY-based Ru(II) and Ir(III) organometallic complexes of avobenzone, a sunscreen material: Potent anticancer agents
Gajendra Gupta et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2018)
Potent Half-Sandwich Iridium(III) and Ruthenium(II) Anticancer Complexes Containing a PO-Chelated Ligand
Qing Du et al.
ORGANOMETALLICS (2018)
Half-Sandwich Iridium and Ruthenium Complexes: Effective Tracking in Cells and Anticancer Studies
JuanJuan Li et al.
INORGANIC CHEMISTRY (2018)
Strong Influence of Ancillary Ligands Containing Benzothiazole or Benzimidazole Rings on Cytotoxicity and Photoactivation of Ru(II) Arene Complexes
Matteo Lari et al.
INORGANIC CHEMISTRY (2018)
Newly Synthesized Heteronuclear Ruthenium(II)/Ferrocene Complexes Suppress the Growth of Mammary Carcinoma in 4T1-Treated BALB/c Mice by Promoting Activation of Antitumor Immunity
Milan M. Milutinovic et al.
ORGANOMETALLICS (2018)
Highly potent half- sandwich iridium and ruthenium complexes as lysosome- targeted imaging and anticancer agents
JuanJuan Li et al.
DALTON TRANSACTIONS (2018)
Synthesis and anticancer properties of ruthenium (II) complexes as potent apoptosis inducers through mitochondrial disruption
Dan Wan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis and Photobiological Activity of Ru(II) Dyads Derived from Pyrrole-2-carboxylate Thionoesters
Deborah A. Smithen et al.
INORGANIC CHEMISTRY (2017)
A Rhodium(III)-Based Inhibitor of Lysine-Specific Histone Demethylase 1 as an Epigenetic Modulator in Prostate Cancer Cells
Chao Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
In Vitro Anticancer Activity and in Vivo Biodistribution of Rhenium(I) Tricarbonyl Aqua Complexes
Kevin M. Knopf et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium(III) complexes
Jian-Jun Cao et al.
CHEMICAL SCIENCE (2017)
Organoruthenium Complexes with CN Ligands are Highly Potent Cytotoxic Agents that Act by a New Mechanism of Action
Vojtech Novohradsky et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials
Leli Zeng et al.
CHEMICAL SOCIETY REVIEWS (2017)
Photo-induced cytotoxicity and anti-metastatic activity of ruthenium(II)-polypyridyl complexes functionalized with tyrosine or tryptophan
Vadde Ramu et al.
DALTON TRANSACTIONS (2017)
Taurine-modified Ru(II)-complex targets cancerous brain cells for photodynamic therapy
Enming Du et al.
CHEMICAL COMMUNICATIONS (2017)
Interstrand DNA covalent binding of two dinuclear Ru(II) complexes. Influence of the extra ring of the bridging ligand on the DNA interaction and cytotoxic activity
Hector J. Lozano et al.
DALTON TRANSACTIONS (2017)
Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer agents
Kai Xiong et al.
BIOCHIMIE (2016)
Heterodinuclear Pt(IV)-Ru(II) anticancer prodrugs to combat both drug resistance and tumor metastasis
Lili Ma et al.
CHEMICAL COMMUNICATIONS (2016)
Overcoming the Achilles' heel of photodynamic therapy
Wenpei Fan et al.
CHEMICAL SOCIETY REVIEWS (2016)
Mono- and Dinuclear Phosphorescent Rhenium(I) Complexes: Impact of Subcellular Localization on Anticancer Mechanisms
Rui-Rong Ye et al.
CHEMISTRY-A EUROPEAN JOURNAL (2016)
Biodistribution of the novel anticancer drug sodium trans-Retrachloridobis(1H-indazole)ruthenate(III)] KP-1339/IT139 in nude BALB/c mice and implications on its mode of action
Anna K. Bytzek et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Photo-induced DNA cleavage and cytotoxicity of a ruthenium(II) arene anticancer complex
Viktor Brabec et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Ru(II)/clotrimazole/diphenylphosphine/bipyridine complexes: Interaction with DNA, BSA and biological potential against tumor cell lines and Mycobacterium tuberculosis
Legna Colina-Vegas et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
The studies on the cytotoxicity in vitro, cellular uptake, cell cycle arrest and apoptosis-inducing properties of ruthenium methylimidazole complex [Ru(MeIm)4(p-cpip)]2+
Lan-mei Chen et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Half-sandwich iridiumIII complexes with pyrazole-substituted heterocyclic frameworks and their biological applications
Sanjay B. Gajera et al.
NEW JOURNAL OF CHEMISTRY (2016)
Synthesis, structures, and DNA and protein binding of ruthenium(II)-p-cymene complexes of substituted pyridylimidazo[1,5-a] pyridine: enhanced cytotoxicity of complexes of ligands appended with a carbazole moiety
Themmila Khamrang et al.
RSC ADVANCES (2016)
Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents
Fang-Xin Wang et al.
SCIENTIFIC REPORTS (2016)
Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents
Yi Li et al.
BIOMATERIALS (2015)
Two novel BODIPY-Ru(II) arene dyads enabling effective photo-inactivation against cancer cells
Tianji Wang et al.
DALTON TRANSACTIONS (2015)
Synthesis, characterization and DNA-binding properties of Ru(II) complexes coordinated by ofloxacin as potential antitumor agents
Chengxi Wang et al.
JOURNAL OF COORDINATION CHEMISTRY (2015)
Selective nuclei accumulation of ruthenium(II) complex enantiomers that target G-quadruplex DNA
Dongdong Sun et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2015)
Structure-Related Mode-of-Action Differences of Anticancer Organoruthenium Complexes with β-Diketonates
Sara Sersen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Synthesis, Structure, DNA/Protein Binding, and Anticancer Activity of Some Half-Sandwich Cyclometalated Rh(III) and Ir(III) Complexes
Sujay Mukhopadhyay et al.
ORGANOMETALLICS (2015)
A Family of Potent Ru(II) Photosensitizers with Enhanced DNA Intercalation: Bimodal Photokillers
Eleftherios K. Pefkianakis et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2015)
Identification of an iridium(III) complex with anti-bacterial and anti-cancer activity
Lihua Lu et al.
SCIENTIFIC REPORTS (2015)
Identification and discrimination of binding sites of an organoruthenium anticancer complex to single-stranded oligonucleotides by mass spectrometry
Suyan Liu et al.
ANALYST (2014)
A Bis(dipyridophenazine)(2-(2-pyridyl)pyrimidine-4-carboxylic acid) ruthenium(II) Complex with Anticancer Action upon Photodeprotection
Tanmaya Joshi et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Recent advances in supramolecular and biological aspects of arene ruthenium(II) complexes
Ashish Kumar Singh et al.
COORDINATION CHEMISTRY REVIEWS (2014)
Dual inhibition of topoisomerases I and IIα by ruthenium(II) complexes containing asymmetric tridentate ligands
Kejie Du et al.
DALTON TRANSACTIONS (2014)
Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(PPY)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity
Suman Kumar Tripathy et al.
DALTON TRANSACTIONS (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
In Vitro and in Vivo Evaluation of Water-Soluble Iminophosphorane Ruthenium(II) Compounds. A Potential Chemotherapeutic Agent for Triple Negative Breast Cancer
Malgorzata Frik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Synthesis, characterisation and cytotoxicity evaluation of rhenium(I) based ester functionalised dinuclear metallacyclophanes
Chowan Ashok Kumar et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2014)
Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C∧I-Chelated and Pyridine Ligands
Zhe Liu et al.
ORGANOMETALLICS (2014)
On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes
Gorakh S. Yellol et al.
CHEMICAL COMMUNICATIONS (2013)
Anticancer activity of ruthenium(II) arene complexes bearing 1,2,3,4-tetrahydroisoquinoline amino alcohol ligands
Madichaba P. Chelopo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium(II) asymmetric complexes
Chen Qian et al.
METALLOMICS (2013)
Rhenium(I) phenanthrolines bearing electron withdrawing CF3 substituents: synthesis, characterization and biological evaluation
Carl Redshaw et al.
RSC ADVANCES (2013)
Ruthenium(II) polypyridyl complexes and DNA-from structural probes to cellular imaging and therapeutics
Martin R. Gill et al.
CHEMICAL SOCIETY REVIEWS (2012)
Synthesis, characterization, DNA-binding and cytotoxic properties of Ru(II) complexes: [Ru(MeIm)4L]2+ (MeIm=1-methylimidazole, L = phen, ip and pip)
Leli Zeng et al.
JOURNAL OF MOLECULAR STRUCTURE (2012)
Molecular and Cellular Characterization of the Biological Effects of Ruthenium(II) Complexes Incorporating 2-Pyridyl-2-pyrimidine-4-carboxylic Acid
Vanessa Pierroz et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Natural product DNA major groove binders
Paris L. Hamilton et al.
NATURAL PRODUCT REPORTS (2012)
Challenges and Opportunities in the Development of Organometallic Anticancer Drugs
Christian G. Hartinger et al.
ORGANOMETALLICS (2012)
Organometallic ruthenium-based antitumor compounds with novel modes of action
Wee Han Ang et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2011)
To intercalate or semiintercalate, or both?
Claudia Turro
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Targeting a ruthenium complex to the nucleus with short peptides
Cindy A. Puckett et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Targeting Mitochondria with Organelle-Specific Compounds: Strategies and Applications
Lema F. Yousif et al.
CHEMBIOCHEM (2009)
Nuclear targets of photodynamic tridentate ruthenium complexes
Ran Zhao et al.
DALTON TRANSACTIONS (2009)
Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs
Sabine H. van Rijt et al.
DRUG DISCOVERY TODAY (2009)
Cytotoxic Rhodium(III) Polypyridyl Complexes Containing the Tris(pyrazolyl)methane Coligand: Synthesis, DNA Binding Properties and Structure-Activity Relationships
Ruth Bieda et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2009)
Fluorescein Redirects a Ruthenium-Octaarginine Conjugate to the Nucleus
Cindy A. Puckett et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Targeting mitochondria
Adam T. Hoye et al.
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Therapeutic nanoparticles for drug delivery in cancer
Kwangjae Cho et al.
CLINICAL CANCER RESEARCH (2008)
Cytotoxicity, cellular uptake, and DNA interactions of new monodentate ruthenium(II) complexes containing terphenyl arenes
Tijana Bugarcic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Synthesis, biological activity, and structure-activity relationships for potent cytotoxic rhodium(III) polypyridyl complexes
Melanie Harlos et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Remarkable anticancer activity of triruthenium-arene clusters compared to tetraruthenium-arene clusters
Bruno Therrien et al.
JOURNAL OF CLUSTER SCIENCE (2007)
Methods to explore cellular uptake of ruthenium complexes
Cindy A. Puckett et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
In vitro evaluation of rhodium and osmium RAPTA analogues:: The case for organometallic anticancer drugs not based on ruthenium
Antoine Dorcier et al.
ORGANOMETALLICS (2006)
From bench to bedside -: preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
Christian G. Hartinger et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
Phototoxicity against tumor cells and sindbis virus by an octahedral rhodium bisbipyridyl complex and evidence for the genome as a target in viral photoinactivation
EL Menon et al.
INORGANIC CHEMISTRY (2004)
Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: Novel recognition mechanisms
HM Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
分享论文
